Sector | Finance | Compare with Sector peers |
Industry | Finance - Investment | Compare with Industry peers |
Website | http://www.shalimaragenciesltd.com | |
Market Cap | 12.19 Cr. | |
Enterprise Value(EV) | Cr. | - |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.11 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 15.12 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 9.51 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.27 | Calculated using Price: 40.61 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.30 Cr. | 3,001,000 Shares |
FaceValue | 10 | |
About Shalimar Agencies Ltd. | ||
Shalimar Agencies is engaged in distribution of pharmaceutical formulations for Healthcare goods. |
1 Day |
|
|
1 Week |
|
-4.98% |
1 Month |
|
-0.47% |
3 Month |
|
-7.03% |
6 Month |
|
-24.64% |
1 Year |
|
-8.45% |
2 Year |
|
+41.25% |
5 Year |
|
+210.0% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.68 | 0.59 | -5 | -4.97 | -2.51 | -2.93 | -2.98 | -3.57 | -2.96 | |
Return on Capital Employed (%) | 0.85 | 0.86 | -4.99 | -4.95 | -2.51 | -2.94 | -2.97 | -3.55 | -2.97 | |
Return on Assets (%) | 0.67 | 0.58 | -4.89 | -4.9 | -2.49 | -2.86 | -2.83 | -3.28 | -2.33 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |
Non Curr. Liab. | |||||||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | |
Non Curr. Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | ||
Curr. Assets | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 9 | 10 | 1 | ||||||
Other Income | 0 | 0 | 0 | 0 | 0 | ||||||
Total Income | 0 | 1 | 9 | 11 | 1 | ||||||
Total Expenditure | 0 | 0 | -10 | -11 | -2 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | |||||||||||
Depreciation | 0 | 0 | |||||||||
Taxation | 0 | ||||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -2 | 0 | -1 | 0 | 1 | 0 | 0 | |||
Cash Fr. Inv. | 0 | 0 | 0 | 1 | 0 | -1 | 0 | ||||
Cash Fr. Finan. | 2 | ||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the period between 01st January 2024 to 31st March 2024. |
Fri, 29 Mar 2024
Closure of Trading Window This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and the Code to Regulate Monitor and Report Trading by Directors Promoters Designated Employees and Specified Connected Persons of the Company of the Company the Trading Window for dealing in the securities of the Company shall remain Closed for all insiders including Designated Persons and their immediate relatives from April 01 2024 till the end of 48 hours after the declaration of the audited financial results of the Company for the fourth quarter and year ended March 31 2024. |
Fri, 09 Feb 2024
Submission Of Un-Audited Financial Results Of The Company U/R 33 Of SEBI (LODR) Regulations 2015 For The 3Rd Quarter 31St December 2023. Submission of Un-audited Financial Results of the Company u/r 33 of SEBI (LODR) Regulations 2015 for the 3rd Quarter 31st December 2023. |
Mon, 22 Apr 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Opening at High |
Closing Below Previous Low |